C
Christopher J L Murray
Researcher at Institute for Health Metrics and Evaluation
Publications - 833
Citations - 393064
Christopher J L Murray is an academic researcher from Institute for Health Metrics and Evaluation. The author has contributed to research in topics: Population & Mortality rate. The author has an hindex of 209, co-authored 754 publications receiving 310329 citations. Previous affiliations of Christopher J L Murray include Harvard University & University of Washington.
Papers
More filters
Journal ArticleDOI
Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015
TL;DR: In this paper, the authors developed new reproducible methods and reanalyse existing data to elucidate detailed time trends, and then applied Loess regression to estimate past trends and forecast to 2015 for 172 countries.
Posted Content
Rethinking Human Security
Gary King,Christopher J L Murray +1 more
TL;DR: In this paper, the authors propose a simple, rigorous, and measurable definition of human security: the expected number of years of future life spent outside the state of generalized poverty, defined as the threshold in any key domain of human well-being.
Journal ArticleDOI
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
Thierry Hercend,James D. Griffin,Armand Bensussan,R E Schmidt,Mary Ann Edson,Agnes Brennan,Christopher J L Murray,Jennifer Daley,Stuart F. Schlossman,Jerome Ritz +9 more
TL;DR: Results strongly supported the view that NKH1A is a "pan-NK" associated antigen, and indicated that at least a fraction of cloned NKH2 + LGL are strongly cytotoxic.
Journal ArticleDOI
The burden of cardiovascular diseases among us states, 1990-2016
Gregory A. Roth,Gregory A. Roth,Catherine O. Johnson,Kalkidan Hassen Abate,Foad Abd-Allah,Muktar Beshir Ahmed,Khurshid Alam,Tahiya Alam,Nelson Alvis-Guzman,Hossein Ansari,Johan Ärnlöv,Tesfay Mehari Atey,Ashish Awasthi,Tadesse Awoke,Aleksandra Barac,Till Bärnighausen,Neeraj Bedi,Derrick A Bennett,Isabela M. Benseñor,Sibhatu Biadgilign,Carlos A Castañeda-Orjuela,Ferrán Catalá-López,Kairat Davletov,Samath D Dharmaratne,Eric L. Ding,Manisha Dubey,Emerito Jose A. Faraon,Talha Farid,Maryam S. Farvid,Valery L. Feigin,João C. Fernandes,Joseph Frostad,Alemseged Aregay Gebru,Johanna M. Geleijnse,Philimon Gona,Max Griswold,Gessessew Bugssa Hailu,Graeme J. Hankey,Hamid Yimam Hassen,Rasmus Havmoeller,Simon I. Hay,Susan R. Heckbert,Caleb Mackay Salpeter Irvine,Spencer L. James,Dube Jara,Amir Kasaeian,Abdur Rahman Khan,Sahil Khera,Abdullah T Khoja,Jagdish Khubchandani,Daniel Kim,Dhaval Kolte,Dharmesh Kumar Lal,Anders Larsson,Shai Linn,Paulo A. Lotufo,Hassan Magdy Abd El Razek,Mohsen Mazidi,Toni Meier,Walter Mendoza,George A. Mensah,Atte Meretoja,Haftay Berhane Mezgebe,Erkin M. Mirrakhimov,Shafiu Mohammed,Andrew E. Moran,Grant Nguyen,Minh Nguyen,Kanyin Liane Ong,Mayowa O. Owolabi,Martin A Pletcher,Farshad Pourmalek,Caroline A. Purcell,Mostafa Qorbani,Mahfuzar Rahman,Rajesh Kumar Rai,Usha Ram,Marissa B Reitsma,Andre M. N. Renzaho,Maria Jesus Rios-Blancas,Saeid Safiri,Joshua A. Salomon,Benn Sartorius,Sadaf G. Sepanlou,Masood Ali Shaikh,Diego Augusto Santos Silva,Saverio Stranges,Rafael Tabarés-Seisdedos,Niguse Tadele Atnafu,Jarnail Singh Thakur,Roman Topor-Madry,Thomas Truelsen,E. Murat Tuzcu,Stefanos Tyrovolas,Kingsley N. Ukwaja,Tommi Vasankari,Vasiliy Victorovich Vlassov,Stein Emil Vollset,Tolassa Wakayo,Robert G. Weintraub,Charles D.A. Wolfe,Abdulhalik Workicho,Gelin Xu,Simon Yadgir,Yuichiro Yano,Paul S. F. Yip,Naohiro Yonemoto,Mustafa Z. Younis,Chuanhua Yu,Zoubida Zaidi,Maysaa El Sayed Zaki,Ben Zipkin,Ashkan Afshin,Emmanuela Gakidou,Stephen S Lim,Ali H. Mokdad,Mohsen Naghavi,Theo Vos,Christopher J L Murray +118 more
TL;DR: Large disparities in total burden of CVD persist between US states despite marked improvements in CVD burden, and increases in risk-deleted CVD DALY rates between 2006 and 2016 in 16 states suggest additional unmeasured risks beyond these traditional factors.
Journal ArticleDOI
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
Katherine E. Battle,Tim C.D. Lucas,Michele Nguyen,Rosalind E. Howes,Anita Nandi,Katherine A. Twohig,Daniel A. Pfeffer,Ewan Cameron,Puja C Rao,Daniel C Casey,Harry S. Gibson,Jennifer Rozier,Ursula Dalrymple,Suzanne H. Keddie,Emma L. Collins,Joseph R Harris,Carlos A. Guerra,Michael P Thorn,Donal Bisanzio,Donal Bisanzio,Nancy Fullman,Chantal Huynh,Xie Rachel Kulikoff,Michael Kutz,Alan D. Lopez,Ali H. Mokdad,Mohsen Naghavi,Grant Nguyen,Katya Anne Shackelford,Theo Vos,Haidong Wang,Stephen S Lim,Christopher J L Murray,Ric N. Price,Ric N. Price,J. Kevin Baird,David L. Smith,Samir Bhatt,Daniel J. Weiss,Simon I. Hay,Peter W. Gething +40 more
TL;DR: These results support global monitoring systems and can inform the optimisation of diagnosis and treatment where P vivax has most impact, and form the malaria estimates for the Global Burden of Disease 2017 study.